[HTML][HTML] RNA methylation and cancer treatment

B Yang, JQ Wang, Y Tan, R Yuan, ZS Chen… - Pharmacological …, 2021 - Elsevier
To this date, over 100 different types of RNA modification have been identified. Methylation
of different RNA species has emerged as a critical regulator of transcript expression. RNA …

[HTML][HTML] Role of m6A writers, erasers and readers in cancer

Z Fang, W Mei, C Qu, J Lu, L Shang, F Cao… - … Hematology & Oncology, 2022 - Springer
Abstract The N (6)-methyladenosine (m6A) modification is the most pervasive modification of
human RNAs. In recent years, an increasing number of studies have suggested that m6A …

[HTML][HTML] ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

Y Chen, Y Zhao, J Chen, C Peng, Y Zhang, R Tong… - Molecular cancer, 2020 - Springer
Abstract Background N6-methyladenosine (m 6 A) modification is an emerging layer of
epigenetic regulation which is widely implicated in the tumorigenicity of hepatocellular …

[HTML][HTML] The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

M Chen, CM Wong - Molecular cancer, 2020 - Springer
Liver cancer is a common cancer worldwide. Although the etiological factors of liver
carcinogenesis are well defined, the underlying molecular mechanisms remain largely …

[HTML][HTML] FTO–a common genetic basis for obesity and cancer

N Lan, Y Lu, Y Zhang, S Pu, H Xi, X Nie, J Liu… - Frontiers in …, 2020 - frontiersin.org
In recent years, the prevalence of obesity and cancer have been rising. Since this poses a
serious threat to human health, the relationship between the two has attracted much …

Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma

Q Zhang, L Xiong, T Wei, Q Liu, L Yan, J Chen, L Dai… - Oncogene, 2023 - nature.com
Emerging evidence has indicated that peroxisome proliferator-activated receptor-gamma
coactivator-1α (PPARGC1A) is involved in hepatocellular carcinoma (HCC). However, its …

[HTML][HTML] Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application

F Zhang, H Liu, M Duan, G Wang, Z Zhang… - Journal of hematology & …, 2022 - Springer
The tumor microenvironment (TME), which is regulated by intrinsic oncogenic mechanisms
and epigenetic modifications, has become a research hotspot in recent years. Characteristic …

[HTML][HTML] Epitranscriptomics in liver disease: basic concepts and therapeutic potential

Z Zhao, J Meng, R Su, J Zhang, J Chen, X Ma… - Journal of hepatology, 2020 - Elsevier
The development of next-generation sequencing technology and the discovery of specific
antibodies targeting chemically modified nucleotides have paved the way for a new era of …

circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1

M Wang, Y Yang, J Yang, J Yang, S Han - Life sciences, 2020 - Elsevier
Aims Hepatocellular carcinoma (HCC), one of the most common cancer, causes the fourth
cancer-related deaths around the world. N6-methyladenosine (m 6 A) has been reported to …

[HTML][HTML] Emerging roles of RNA methylation in gastrointestinal cancers

S Xie, W Chen, K Chen, Y Chang, F Yang, A Lin… - Cancer cell …, 2020 - Springer
RNA methylation has emerged as a fundamental process in epigenetic regulation.
Accumulating evidences indicate that RNA methylation is essential for many biological …